Siegel, Scott D, Antoni, Michael H, Fletcher, Mary Ann et al. · Journal of psychosomatic research · 2006 · DOI
This study looked at whether a specific immune system measure called natural killer cell activity (NKCA) could help identify different subgroups of ME/CFS patients. Researchers compared 41 women with ME/CFS who had low NKCA levels to those with normal levels, measuring their cognitive ability and symptoms. They found that patients with low NKCA reported worse cognitive problems, more daytime dysfunction, and performed worse on thinking tests compared to those with normal NKCA levels.
ME/CFS is highly heterogeneous, and identifying biological subgroups could lead to more targeted treatments and better patient stratification in research. This study provides preliminary evidence that immune dysfunction (reduced NK cell activity) correlates with specific symptom patterns, particularly cognitive impairment, offering a potential framework for understanding patient diversity. Finding reliable subgroup markers is essential for advancing personalized medicine approaches in ME/CFS.
This study does not prove that low NKCA causes cognitive dysfunction or other symptoms—it only shows an association in a small, female-only sample. It cannot establish whether reduced NKCA is a primary driver of symptoms or a secondary consequence of the disease. The findings require replication in larger, more diverse populations before NKCA can be considered a validated subgroup marker for clinical use.